SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-032105
Filing Date
2023-09-12
Accepted
2023-09-12 17:27:50
Documents
3
Period of Report
2023-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1694554060.html 3  
1 FORM 3 wk-form3_1694554060.xml 3 5058
2 EX-24 mrtx_-xsectionx16xpowerx.htm EX-24 3795
3 GRAPHIC mrtx_-xsectionx16xpowerx001.jpg GRAPHIC 203177
  Complete submission text file 0001628280-23-032105.txt   290088
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address
Ondrey Aaron (Reporting) CIK: 0001991078 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 231251028